Gutierrez-Ramos Jose-Carlos
Insider CIK 1667657 · MNTA Director · SYBX See Remarks, Director · EVLO Director · BCYC Director · DHR SVP, Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DHR DANAHER CORP /DE/ | A Award | 2026-08-04 | 2026-08-06 | 13,477 | — | $0 | 32,495 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award | 2026-08-04 | 2026-08-06 | 13,477 | — | $0 | 32,495 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2026-03-01 | 2026-03-03 | 17,964 | — | $0 | 17,964 | SEC↗ |
| DHR DANAHER CORP /DE/ | F Tax w/h | 2026-03-01 | 2026-03-03 | 284 | $210.64 | $59.8K | 19,018 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award | 2026-03-01 | 2026-03-03 | 6,647 | — | $0 | 19,302 | SEC↗ |
| DHR DANAHER CORP /DE/ | F Tax w/h | 2026-02-24 | 2026-02-25 | 344 | $209.19 | $72.0K | 12,655 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award | 2026-02-04 | 2026-02-06 | 1,695 | — | $0 | 12,999 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2026-02-02 | 2026-02-04 | 275 | $218.89 | $60.2K | 1,447 | SEC↗ |
| DHR DANAHER CORP /DE/ | F Tax w/h | 2026-02-02 | 2026-02-04 | 852 | $223.42 | $190.4K | 11,304 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS PLC | A Award deriv | 2026-01-02 | 2026-01-06 | 19,000 | — | $0 | 19,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS PLC | A Award | 2026-01-02 | 2026-01-06 | 9,500 | — | $0 | 32,500 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2025-03-01 | 2025-03-04 | 24,067 | — | $0 | 24,067 | SEC↗ |
| DHR DANAHER CORP /DE/ | F Tax w/h | 2025-03-01 | 2025-03-04 | 216 | $207.76 | $44.9K | 12,156 | SEC↗ |
| DHR DANAHER CORP /DE/ | F Tax w/h | 2025-02-24 | 2025-02-25 | 586 | $211.14 | $123.7K | 12,372 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2025-02-01 | 2025-02-04 | 241 | $222.74 | $53.7K | 1,172 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS PLC | A Award deriv | 2025-01-02 | 2025-01-06 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS PLC | A Award | 2025-01-02 | 2025-01-06 | 6,250 | — | $0 | 23,000 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2024-03-01 | 2024-03-05 | 6,979 | — | $0 | 6,979 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2024-03-01 | 2024-03-05 | 16,285 | — | $0 | 16,285 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award | 2024-03-01 | 2024-03-05 | 2,932 | — | $0 | 12,958 | SEC↗ |
| DHR DANAHER CORP /DE/ | F Tax w/h | 2024-02-26 | 2024-02-27 | 866 | $253.84 | $219.8K | 10,026 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award | 2024-02-21 | 2024-02-23 | 3,155 | — | $0 | 10,892 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2024-02-01 | 2024-02-02 | 216 | — | $0 | 931 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award deriv | 2024-01-02 | 2024-01-04 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award | 2024-01-02 | 2024-01-04 | 6,000 | — | $0 | 16,750 | SEC↗ |
| DHR DANAHER CORP /DE/ | S Sale | 2023-08-21 | 2023-08-22 | 590 | $250.54 | $147.8K | 6,939 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DHR DANAHER CORP /DE/ | S Sale | 2023-05-01 | 2023-05-02 | 500 | $242.19 | $121.1K | 7,529 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2023-04-28 | 2023-05-01 | 1 | $236.91 | $171 | 635 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2023-02-24 | 2023-02-28 | 10,849 | — | $0 | 10,849 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2023-02-24 | 2023-02-28 | 16,274 | — | $0 | 16,274 | SEC↗ |
| DHR DANAHER CORP /DE/ | F Tax w/h | 2023-02-24 | 2023-02-28 | 481 | $249.12 | $119.8K | 4,014 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award | 2023-02-24 | 2023-02-28 | 4,015 | — | $0 | 8,029 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2023-02-01 | 2023-02-02 | 461 | $267.50 | $123.3K | 635 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2023-01-27 | 2023-01-30 | 0 | $265.98 | $43 | 174 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award deriv | 2023-01-03 | 2023-01-05 | 11,500 | — | $0 | 11,500 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award | 2023-01-03 | 2023-01-05 | 5,750 | — | $0 | 10,750 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2022-10-28 | 2022-10-31 | 0 | $251.80 | $43 | 173 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2022-07-29 | 2022-08-02 | 0 | $291.47 | $44 | 173 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2022-04-01 | 2022-04-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2022-02-24 | 2022-02-28 | 12,626 | — | $0 | 12,626 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award | 2022-02-24 | 2022-02-28 | 2,210 | — | $0 | 4,495 | SEC↗ |
| DHR DANAHER CORP /DE/ | F Tax w/h | 2022-02-24 | 2022-02-28 | 260 | $271.56 | $70.6K | 2,285 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2022-02-01 | 2022-02-02 | 173 | $285.79 | $49.4K | 173 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award deriv | 2022-01-03 | 2022-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award | 2022-01-03 | 2022-01-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | A Award deriv | 2021-03-17 | 2021-03-19 | 32,000 | — | $0 | 32,000 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award deriv | 2021-02-24 | 2021-02-26 | 13,190 | $223.00 | $2.94M | 13,190 | SEC↗ |
| DHR DANAHER CORP /DE/ | A Award | 2021-02-24 | 2021-02-26 | 2,545 | $223.00 | $567.5K | 2,545 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 8,855 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 25,000 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 25,000 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 11,207 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 20,000 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2020-08-19 | 2020-08-20 | 10,000 | — | $0 | 20,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-08-19 | 2020-08-20 | 10,000 | $52.09 | $520.9K | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2020-08-19 | 2020-08-20 | 10,000 | $8.59 | $85.9K | 10,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2020-06-23 | 2020-06-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-01-21 | 2020-01-23 | 4,356 | $29.09 | $126.7K | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-01-21 | 2020-01-23 | 5,734 | $29.10 | $166.9K | 4,356 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2019-06-20 | 2019-06-21 | 4,356 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2019-06-20 | 2019-06-21 | 4,356 | — | $0 | 10,090 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2019-06-19 | 2019-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 31,380 | — | $0 | 31,380 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2018-06-20 | 2018-06-22 | 5,734 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2018-06-20 | 2018-06-22 | 4,356 | — | $0 | 4,356 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2018-06-20 | 2018-06-22 | 8,855 | — | $0 | 8,855 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2018-06-20 | 2018-06-22 | 5,734 | — | $0 | 5,734 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2018-03-14 | 2018-03-16 | 120,540 | — | $0 | 120,540 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2017-06-20 | 2017-06-22 | 5,734 | — | $0 | 5,734 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2017-06-20 | 2017-06-22 | 11,207 | — | $0 | 11,207 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2016-03-09 | 2016-03-11 | 30,000 | — | $0 | 30,000 | SEC↗ |